Skip to main content
Top
Published in: BMC Public Health 1/2007

Open Access 01-12-2007 | Research article

Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002

Authors: Dolly Baliunas, Jayadeep Patra, Jürgen Rehm, Svetlana Popova, Benjamin Taylor

Published in: BMC Public Health | Issue 1/2007

Login to get access

Abstract

Background

Smoking is one of the most important risk factors for burden of disease. Our objective was to estimate the number of hospital diagnoses and days of treatment attributable to smoking for Canada, 2002.

Methods

Distribution of exposure was taken from a major national survey of Canada, the Canadian Community Health Survey. For chronic diseases, risk relations were taken from the published literature and combined with exposure to calculate age- and sex-specific smoking-attributable fractions (SAFs). For fire deaths, SAFs were taken directly from available statistics. Information on morbidity, with cause of illness coded according to the International Classification of Diseases version 10, was obtained from the Canadian Institute for Health Information.

Results

For Canada in 2002, 339,179 of all hospital diagnoses were estimated to be attributable to smoking and 2,210,155 acute care hospital days. Ischaemic heart disease was the largest single category in terms of hospital days accounting for 21 percent, followed by lung cancer at 9 percent. Smoking-attributable acute care hospital days cost over $2.5 billion in Canada in 2002.

Conclusion

Since the last major project produced estimates of this type, the rate of hospital days per 100,000 population has decreased by 33.8 percent. Several possible factors may have contributed to the decline in the rate of smoking-attributable hospital days: a drop in smoking prevalence, a decline in overall hospital days, and a shift in distribution of disease categories. Smoking remains a significant health, social, and economic burden in Canada.
Literature
1.
go back to reference U.S.Department of Health and Human Services: The health consequences of smoking: a report of the Surgeon General. 2004, Atlanta, GA., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health. U.S.Department of Health and Human Services: The health consequences of smoking: a report of the Surgeon General. 2004, Atlanta, GA., Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health.
2.
go back to reference Single E, Robson L, Xie X, Rehm J: The costs of substance abuse in Canada. 1996, Ottawa, Canadian Centre on Substance Abuse Single E, Robson L, Xie X, Rehm J: The costs of substance abuse in Canada. 1996, Ottawa, Canadian Centre on Substance Abuse
3.
go back to reference English DR, Holman CDJ, Milne E, Winter MJ, Hulse GK, Codde G, Bower CI, Corti B, de Klerk N, Knuiman MW, Kurinczukn JJ, Lewin GF, Ryan GA: The quantification of drug caused morbidity and mortality in Australia 1995. 1995, Canberra, Australia, Commonwealth Department of Human Services and Health. English DR, Holman CDJ, Milne E, Winter MJ, Hulse GK, Codde G, Bower CI, Corti B, de Klerk N, Knuiman MW, Kurinczukn JJ, Lewin GF, Ryan GA: The quantification of drug caused morbidity and mortality in Australia 1995. 1995, Canberra, Australia, Commonwealth Department of Human Services and Health.
4.
go back to reference Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, Popova S, Sarnocinska-Hart A, Taylor B: The costs of substance abuse in Canada 2002. 2006, Ottawa, Canadian Centre on Substance Abuse Rehm J, Baliunas D, Brochu S, Fischer B, Gnam W, Patra J, Popova S, Sarnocinska-Hart A, Taylor B: The costs of substance abuse in Canada 2002. 2006, Ottawa, Canadian Centre on Substance Abuse
5.
go back to reference Canada S: Canadian Community Health Survey, Cycle 2.1 [Catalogue 82M0013XCB]. 2003, Ottawa, Statistics Canada Canada S: Canadian Community Health Survey, Cycle 2.1 [Catalogue 82M0013XCB]. 2003, Ottawa, Statistics Canada
6.
go back to reference CIHI - Canadian Institute for Health Information: Data quality documentation: discharge abstract database 2002-2003. 2004, Ottawa, CIHI CIHI - Canadian Institute for Health Information: Data quality documentation: discharge abstract database 2002-2003. 2004, Ottawa, CIHI
7.
go back to reference Walter SD: The estimation of interpretation of attributable risk in health research. Biometrics. 1976, 32: 829-849. 10.2307/2529268.CrossRefPubMed Walter SD: The estimation of interpretation of attributable risk in health research. Biometrics. 1976, 32: 829-849. 10.2307/2529268.CrossRefPubMed
8.
go back to reference Walter SD: Prevention of multifactorial disease. American Journal of Epidemiology. 1980, 112: 409-416.PubMed Walter SD: Prevention of multifactorial disease. American Journal of Epidemiology. 1980, 112: 409-416.PubMed
9.
go back to reference Council of Canadian Fire Marshalls and Fire Commissioners: Fire Losses in Canada Annual Report, 2000. 2003, Council of Canadian Fire Marshals and Fire Commissioners. Council of Canadian Fire Marshalls and Fire Commissioners: Fire Losses in Canada Annual Report, 2000. 2003, Council of Canadian Fire Marshals and Fire Commissioners.
10.
go back to reference CIHI - Canadian Institute for Health Information: Canadian MIS database: hospital finance performance indicators 1999-2000 to 2001-2002. 2004, Ottawa, CIHI CIHI - Canadian Institute for Health Information: Canadian MIS database: hospital finance performance indicators 1999-2000 to 2001-2002. 2004, Ottawa, CIHI
11.
go back to reference Canada S: Estimates of population by age and sex for Canada, Provinces and Territories. 2006, Ottawa, Statistics Canada Canada S: Estimates of population by age and sex for Canada, Provinces and Territories. 2006, Ottawa, Statistics Canada
12.
go back to reference Canada S: General Social Survey, Cycle 6 (1991)[catalogue 89F0115XIE]. 1992, Ottawa, Statistics Canada Canada S: General Social Survey, Cycle 6 (1991)[catalogue 89F0115XIE]. 1992, Ottawa, Statistics Canada
14.
go back to reference Patra J, Taylor B, Rehm J, Popova S, Baliunas D: Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period. Canadian Journal of Public Health. 2007, 98: 228-234.PubMed Patra J, Taylor B, Rehm J, Popova S, Baliunas D: Substance-attributable morbidity and mortality changes to Canada's epidemiological profile: measurable differences over a ten-year period. Canadian Journal of Public Health. 2007, 98: 228-234.PubMed
15.
go back to reference Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A: Tobacco smoking and gastric cancer: review and meta-analysis. International Journal of Cancer. 1997, 72: 573-10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O.CrossRef Tredaniel J, Boffetta P, Buiatti E, Saracci R, Hirsch A: Tobacco smoking and gastric cancer: review and meta-analysis. International Journal of Cancer. 1997, 72: 573-10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O.CrossRef
16.
go back to reference Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P, Brennan P, Darby SC, Forastiere F, Fortes C, Gaborieau V, Gerken M, Gonzales CA, Jockel KH, Kreuzer M, Merletti F, Nyberg F, Pershagen G, Pohlabeln H, Rosch F, Whitley E, Wichmann HE, Zambon P: Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. International Journal of Cancer. 2001, 91: 876-887. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1139>3.0.CO;2-7.CrossRefPubMed Simonato L, Agudo A, Ahrens W, Benhamou E, Benhamou S, Boffetta P, Brennan P, Darby SC, Forastiere F, Fortes C, Gaborieau V, Gerken M, Gonzales CA, Jockel KH, Kreuzer M, Merletti F, Nyberg F, Pershagen G, Pohlabeln H, Rosch F, Whitley E, Wichmann HE, Zambon P: Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. International Journal of Cancer. 2001, 91: 876-887. 10.1002/1097-0215(200102)9999:9999<::AID-IJC1139>3.0.CO;2-7.CrossRefPubMed
17.
go back to reference Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N: Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes & Control. 2003, 14: 805-814. 10.1023/B:CACO.0000003811.98261.3e.CrossRef Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N: Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes & Control. 2003, 14: 805-814. 10.1023/B:CACO.0000003811.98261.3e.CrossRef
18.
go back to reference Zeegers MP, Tan FE, Dorant E, van Den Brandt PA: The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. [Review] [87 refs]. Cancer. 2000, 89: 630-639. 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q.CrossRefPubMed Zeegers MP, Tan FE, Dorant E, van Den Brandt PA: The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. [Review] [87 refs]. Cancer. 2000, 89: 630-639. 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q.CrossRefPubMed
19.
go back to reference Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P: Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. International Journal of Cancer. 2005, 114: 101-108. 10.1002/ijc.20618.CrossRefPubMed Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P: Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. International Journal of Cancer. 2005, 114: 101-108. 10.1002/ijc.20618.CrossRefPubMed
20.
go back to reference Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, t'Mannetje A, Kogevinas M, Boffetta P: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. International Journal of Cancer. 2000, 86: 289-294. 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M.CrossRefPubMed Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jockel KH, Donato F, Serra C, Wahrendorf J, Hours M, t'Mannetje A, Kogevinas M, Boffetta P: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. International Journal of Cancer. 2000, 86: 289-294. 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M.CrossRefPubMed
21.
go back to reference Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jockel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P: The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes & Control. 2001, 12: 411-417. 10.1023/A:1011214222810.CrossRef Brennan P, Bogillot O, Greiser E, Chang-Claude J, Wahrendorf J, Cordier S, Jockel KH, Lopez-Abente G, Tzonou A, Vineis P, Donato F, Hours M, Serra C, Bolm-Audorff U, Schill W, Kogevinas M, Boffetta P: The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes & Control. 2001, 12: 411-417. 10.1023/A:1011214222810.CrossRef
22.
go back to reference Brownson RC, Novotny TE, Perry MC: Cigarette smoking and adult leukemia: a meta-analysis. Archives of Internal Medicine. 1993, 153: 469-475. 10.1001/archinte.153.4.469.CrossRefPubMed Brownson RC, Novotny TE, Perry MC: Cigarette smoking and adult leukemia: a meta-analysis. Archives of Internal Medicine. 1993, 153: 469-475. 10.1001/archinte.153.4.469.CrossRefPubMed
23.
go back to reference Law MR, Morris JK, Wald NJ: Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence.[see comment]. British Medical Journal. 1997, 315: 973-980.CrossRefPubMedPubMedCentral Law MR, Morris JK, Wald NJ: Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence.[see comment]. British Medical Journal. 1997, 315: 973-980.CrossRefPubMedPubMedCentral
24.
go back to reference Law MR, Wald NJ: Environmental tobacco smoke and ischemic heart disease. Progress in Cardiovascular Diseases. 2003, 46: 31-38. 10.1016/S0033-0620(03)00078-1.CrossRefPubMed Law MR, Wald NJ: Environmental tobacco smoke and ischemic heart disease. Progress in Cardiovascular Diseases. 2003, 46: 31-38. 10.1016/S0033-0620(03)00078-1.CrossRefPubMed
Metadata
Title
Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002
Authors
Dolly Baliunas
Jayadeep Patra
Jürgen Rehm
Svetlana Popova
Benjamin Taylor
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2007
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-7-247

Other articles of this Issue 1/2007

BMC Public Health 1/2007 Go to the issue